Cargando…
Pericyte, but not astrocyte, hypoxia inducible factor-1 (HIF-1) drives hypoxia-induced vascular permeability in vivo
BACKGROUND: Ways to prevent disease-induced vascular modifications that accelerate brain damage remain largely elusive. Improved understanding of perivascular cell signalling could provide unparalleled insight as these cells impact vascular stability and functionality of the neurovascular unit as a...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760662/ https://www.ncbi.nlm.nih.gov/pubmed/35033138 http://dx.doi.org/10.1186/s12987-021-00302-y |
_version_ | 1784633369877807104 |
---|---|
author | Baumann, Julia Tsao, Chih-Chieh Patkar, Shalmali Huang, Sheng-Fu Francia, Simona Magnussen, Synnøve Norvoll Gassmann, Max Vogel, Johannes Köster-Hegmann, Christina Ogunshola, Omolara O. |
author_facet | Baumann, Julia Tsao, Chih-Chieh Patkar, Shalmali Huang, Sheng-Fu Francia, Simona Magnussen, Synnøve Norvoll Gassmann, Max Vogel, Johannes Köster-Hegmann, Christina Ogunshola, Omolara O. |
author_sort | Baumann, Julia |
collection | PubMed |
description | BACKGROUND: Ways to prevent disease-induced vascular modifications that accelerate brain damage remain largely elusive. Improved understanding of perivascular cell signalling could provide unparalleled insight as these cells impact vascular stability and functionality of the neurovascular unit as a whole. Identifying key drivers of astrocyte and pericyte responses that modify cell–cell interactions and crosstalk during injury is key. At the cellular level, injury-induced outcomes are closely entwined with activation of the hypoxia-inducible factor-1 (HIF-1) pathway. Studies clearly suggest that endothelial HIF-1 signalling increases blood–brain barrier permeability but the influence of perivascular HIF-1 induction on outcome is unknown. Using novel mouse lines with astrocyte and pericyte targeted HIF-1 loss of function, we herein show that vascular stability in vivo is differentially impacted by perivascular hypoxia-induced HIF-1 stabilization. METHODS: To facilitate HIF-1 deletion in adult mice without developmental complications, novel Cre-inducible astrocyte-targeted (GFAP-CreER(T2); HIF-1α(fl/fl) and GLAST-CreER(T2); HIF-1α(fl/fl)) and pericyte-targeted (SMMHC-CreER(T2); HIF-1α(fl/fl)) transgenic animals were generated. Mice in their home cages were exposed to either normoxia (21% O(2)) or hypoxia (8% O(2)) for 96 h in an oxygen-controlled humidified glove box. All lines were similarly responsive to hypoxic challenge and post-Cre activation showed significantly reduced HIF-1 target gene levels in the individual cells as predicted. RESULTS: Unexpectedly, hypoxia-induced vascular remodelling was unaffected by HIF-1 loss of function in the two astrocyte lines but effectively blocked in the pericyte line. In correlation, hypoxia-induced barrier permeability and water accumulation were abrogated only in pericyte targeted HIF-1 loss of function mice. In contrast to expectation, brain and serum levels of hypoxia-induced VEGF, TGF-β and MMPs (genes known to mediate vascular remodelling) were unaffected by HIF-1 deletion in all lines. However, in agreement with the permeability data, immunofluorescence and electron microscopy showed clear prevention of hypoxia-induced tight junction disruption in the pericyte loss of function line. CONCLUSION: This study shows that pericyte but not astrocyte HIF-1 stabilization modulates endothelial tight junction functionality and thereby plays a pivotal role in hypoxia-induced vascular dysfunction. Whether the cells respond similarly or differentially to other injury stimuli will be of significant relevance. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12987-021-00302-y. |
format | Online Article Text |
id | pubmed-8760662 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-87606622022-01-18 Pericyte, but not astrocyte, hypoxia inducible factor-1 (HIF-1) drives hypoxia-induced vascular permeability in vivo Baumann, Julia Tsao, Chih-Chieh Patkar, Shalmali Huang, Sheng-Fu Francia, Simona Magnussen, Synnøve Norvoll Gassmann, Max Vogel, Johannes Köster-Hegmann, Christina Ogunshola, Omolara O. Fluids Barriers CNS Research BACKGROUND: Ways to prevent disease-induced vascular modifications that accelerate brain damage remain largely elusive. Improved understanding of perivascular cell signalling could provide unparalleled insight as these cells impact vascular stability and functionality of the neurovascular unit as a whole. Identifying key drivers of astrocyte and pericyte responses that modify cell–cell interactions and crosstalk during injury is key. At the cellular level, injury-induced outcomes are closely entwined with activation of the hypoxia-inducible factor-1 (HIF-1) pathway. Studies clearly suggest that endothelial HIF-1 signalling increases blood–brain barrier permeability but the influence of perivascular HIF-1 induction on outcome is unknown. Using novel mouse lines with astrocyte and pericyte targeted HIF-1 loss of function, we herein show that vascular stability in vivo is differentially impacted by perivascular hypoxia-induced HIF-1 stabilization. METHODS: To facilitate HIF-1 deletion in adult mice without developmental complications, novel Cre-inducible astrocyte-targeted (GFAP-CreER(T2); HIF-1α(fl/fl) and GLAST-CreER(T2); HIF-1α(fl/fl)) and pericyte-targeted (SMMHC-CreER(T2); HIF-1α(fl/fl)) transgenic animals were generated. Mice in their home cages were exposed to either normoxia (21% O(2)) or hypoxia (8% O(2)) for 96 h in an oxygen-controlled humidified glove box. All lines were similarly responsive to hypoxic challenge and post-Cre activation showed significantly reduced HIF-1 target gene levels in the individual cells as predicted. RESULTS: Unexpectedly, hypoxia-induced vascular remodelling was unaffected by HIF-1 loss of function in the two astrocyte lines but effectively blocked in the pericyte line. In correlation, hypoxia-induced barrier permeability and water accumulation were abrogated only in pericyte targeted HIF-1 loss of function mice. In contrast to expectation, brain and serum levels of hypoxia-induced VEGF, TGF-β and MMPs (genes known to mediate vascular remodelling) were unaffected by HIF-1 deletion in all lines. However, in agreement with the permeability data, immunofluorescence and electron microscopy showed clear prevention of hypoxia-induced tight junction disruption in the pericyte loss of function line. CONCLUSION: This study shows that pericyte but not astrocyte HIF-1 stabilization modulates endothelial tight junction functionality and thereby plays a pivotal role in hypoxia-induced vascular dysfunction. Whether the cells respond similarly or differentially to other injury stimuli will be of significant relevance. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12987-021-00302-y. BioMed Central 2022-01-15 /pmc/articles/PMC8760662/ /pubmed/35033138 http://dx.doi.org/10.1186/s12987-021-00302-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Baumann, Julia Tsao, Chih-Chieh Patkar, Shalmali Huang, Sheng-Fu Francia, Simona Magnussen, Synnøve Norvoll Gassmann, Max Vogel, Johannes Köster-Hegmann, Christina Ogunshola, Omolara O. Pericyte, but not astrocyte, hypoxia inducible factor-1 (HIF-1) drives hypoxia-induced vascular permeability in vivo |
title | Pericyte, but not astrocyte, hypoxia inducible factor-1 (HIF-1) drives hypoxia-induced vascular permeability in vivo |
title_full | Pericyte, but not astrocyte, hypoxia inducible factor-1 (HIF-1) drives hypoxia-induced vascular permeability in vivo |
title_fullStr | Pericyte, but not astrocyte, hypoxia inducible factor-1 (HIF-1) drives hypoxia-induced vascular permeability in vivo |
title_full_unstemmed | Pericyte, but not astrocyte, hypoxia inducible factor-1 (HIF-1) drives hypoxia-induced vascular permeability in vivo |
title_short | Pericyte, but not astrocyte, hypoxia inducible factor-1 (HIF-1) drives hypoxia-induced vascular permeability in vivo |
title_sort | pericyte, but not astrocyte, hypoxia inducible factor-1 (hif-1) drives hypoxia-induced vascular permeability in vivo |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760662/ https://www.ncbi.nlm.nih.gov/pubmed/35033138 http://dx.doi.org/10.1186/s12987-021-00302-y |
work_keys_str_mv | AT baumannjulia pericytebutnotastrocytehypoxiainduciblefactor1hif1driveshypoxiainducedvascularpermeabilityinvivo AT tsaochihchieh pericytebutnotastrocytehypoxiainduciblefactor1hif1driveshypoxiainducedvascularpermeabilityinvivo AT patkarshalmali pericytebutnotastrocytehypoxiainduciblefactor1hif1driveshypoxiainducedvascularpermeabilityinvivo AT huangshengfu pericytebutnotastrocytehypoxiainduciblefactor1hif1driveshypoxiainducedvascularpermeabilityinvivo AT franciasimona pericytebutnotastrocytehypoxiainduciblefactor1hif1driveshypoxiainducedvascularpermeabilityinvivo AT magnussensynnøvenorvoll pericytebutnotastrocytehypoxiainduciblefactor1hif1driveshypoxiainducedvascularpermeabilityinvivo AT gassmannmax pericytebutnotastrocytehypoxiainduciblefactor1hif1driveshypoxiainducedvascularpermeabilityinvivo AT vogeljohannes pericytebutnotastrocytehypoxiainduciblefactor1hif1driveshypoxiainducedvascularpermeabilityinvivo AT kosterhegmannchristina pericytebutnotastrocytehypoxiainduciblefactor1hif1driveshypoxiainducedvascularpermeabilityinvivo AT ogunsholaomolarao pericytebutnotastrocytehypoxiainduciblefactor1hif1driveshypoxiainducedvascularpermeabilityinvivo |